Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer

Published:2020-10-02 Issue:40 Volume:99 Page:e21965
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhou Shunkai,Huang Rongzhi,Cao Yunpeng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference62 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology;Ettinger;J Natl Compr Canc Netw,2017

4. Novel insights into the systemic treatment of lung cancer malignant pleural effusion;Tissot;Clin Respir J,2019

5. Non-small cell lung cancer: current treatment and future advances;Zappa;Transl Lung Cancer Res,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of ctDNA in early diagnosis, treatment and prognosis of patients with non-small cell lung cancer;Future Oncology;2024-07-29

2. The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications;Frontiers in Immunology;2023-11-29

3. The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies;Cancer Investigation;2023-06-18

4. Circulating tumor DNA (ctDNA) as a biomarker for lung cancer: Early detection, monitoring and therapy prediction;Tumor Biology;2023-05-26

5. Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review;Lung Cancer: Targets and Therapy;2023-02